{"id":53075,"date":"2020-09-22T10:00:10","date_gmt":"2020-09-22T08:00:10","guid":{"rendered":"http:\/\/www.veeva.com\/eu\/?post_type=resources&p=53075"},"modified":"2023-10-27T16:08:38","modified_gmt":"2023-10-27T14:08:38","slug":"medis-selects-veeva-crm-to-deliver-personalized-experiences-to-healthcare-professionals","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/eu\/resources\/medis-selects-veeva-crm-to-deliver-personalized-experiences-to-healthcare-professionals\/","title":{"rendered":"Medis Selects Veeva CRM to Deliver Personalized Experiences to Healthcare Professionals"},"content":{"rendered":"

Complete view of the customer enables field teams to
\ndrive relevant, timely, and compliant engagement across all channels<\/em><\/p>\n

BARCELONA, Spain \u2014 21 Sept, 2020<\/strong> \u2014 Veeva Systems<\/a> (NYSE: VEEV) today announced that Medis has switched to multichannel Veeva CRM<\/a> in 15 countries across Central and Eastern Europe to advance its commercial strategy and drive more efficient and effective interactions with healthcare professionals (HCPs).<\/p>\n

\u201cVeeva CRM gives our teams a flexible solution that adapts to the unique go to market strategies of every customer,\u201d said Kristina Jeri\u010d, multichannel implementation lead at Medis. \u201cNow, our field teams can get the customer insights they need to quickly drive targeted, relevant interactions with HCPs.\u201d<\/p>\n

Medis is a leading independent medical marketing company that specializes in the commercialization of innovative pharmaceutical products. The company needed a CRM solution to effectively execute their customers\u2019 commercial and medical strategies with speed and compliance. With Veeva CRM, Medis can now efficiently deliver compliant, tailored experiences to HCPs across all channels, including face-to-face, email, and web.<\/p>\n

\u201cVeeva CRM offers Medis\u2019 field teams advanced mobility, multichannel capabilities, and real-time insights to drive engagement with the right customer in the right channel at the right time,\u201d said David Logue, senior vice president of commercial strategy at Veeva. \u201cMedis\u2019 field teams can now drive more efficient and effective HCP engagement while maintaining compliance.\u201d<\/p>\n

As part of multichannel Veeva CRM, Medis is implementing Veeva CRM<\/a>, Veeva CLM<\/a>, Veeva CRM Engage Meeting<\/a>, and Veeva CRM Approved Email<\/a>. Learn more about Veeva commercial solutions at Veeva Commercial & Medical Summit Online, Europe, November 17-18. The event is only open to life sciences industry professionals. Register for the virtual event at veeva.com\/Summit<\/a>.<\/p>\n

Additional Information<\/strong>
\nFor more on multichannel Veeva CRM, visit: veeva.com\/eu\/CRM<\/a>
\nConnect with Veeva on LinkedIn: linkedin.com\/company\/veeva-systems<\/a>
\nFollow @Veeva_EU on Twitter: twitter.com\/Veeva_EU<\/a>
\nLike Veeva on Facebook: facebook.com\/veevasystems<\/a><\/p>\n

About Medis<\/strong>
\nMedis is a medical marketing company focused on commercialization of innovative pharmaceutical products, with emphasis on specialty drugs, medical equipment and self-care brands. Medis aims at making the most advanced and effective medical treatments accessible to every patient in Central and Eastern Europe region, by leveraging its marketing know-how, scientific expertise and product knowledge. It is headquartered in the Ljubljana, Slovenia, founded in 1989, and employs more than 350. In 2019, the company achieved sales of \u20ac118 million. Learn more about Medis at www.medis.health\/en\/<\/a>.<\/p>\n

About Veeva Systems<\/strong>
\nVeeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 900 customers, ranging from the world\u2019s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com\/eu<\/a>.<\/p>\n

Forward-looking Statements<\/strong>
\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended July 31, 2020. This is available on the company\u2019s website at veeva.com<\/a> under the Investors section and on the SEC\u2019s website at sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n

###<\/p>\n

Contact:<\/strong><\/p>\n

Veeva Systems
\npr@veeva.com<\/a><\/p>\n

Deivis Mercado
\nVeeva Systems
\n925-226-8821
\ndeivis.mercado@veeva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Complete view of the customer helps field teams drive relevant, timely, and compliant engagement.<\/p>\n","protected":false},"featured_media":53102,"parent":0,"template":"","class_list":["post-53075","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-area-20-commercial","resource-product-20-crm","resource-type-news-press-release"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t